Neuren Pharmaceuticals secures European approval for DAYBU (trofinetide) drug
Neuren Pharmaceuticals (ASX:NEU) secured European Commission marketing authorisation for DAYBU (trofinetide).
Every story in this category, newest first.
Neuren Pharmaceuticals (ASX:NEU) secured European Commission marketing authorisation for DAYBU (trofinetide).
Educational software maker 3P Learning (ASX:3PL) delivered a 26% increase in full-year underlying EBITDA to $19.5 million in FY26.
Mader Group (ASX:MAD) reported record full-year FY26 revenue of $1 billion, representing a 15% increase.
Peet (ASX:PPC) delivered a net operating profit of $103.4 million for the 2026 financial year, driven by higher property settlement prices and strong market conditions.
Verbrec (ASX:VBC) executed several new agreements totalling $16 million for engineering, operations, and cybersecurity projects.
Israeli officials have accused Hamas of using kites and balloons to plan attacks on its territory. The Iran-backed militant group was given until Wednesday to rein in their use - or face repercussions. Bloomberg's Dan Williams reports from Jerusalem.
Turkey's central bank said it would resume weekly repo auctions at its 37% policy rate. The decision is a step towards normalizing funding conditions as the central bank bets the worst of the Iran War's economic fallout has passed. Selva Demiralp, Professor of Economics at Koç University spoke to Bloomberg's Abeer Abu Omar on the move from the Central Bank & its impact on inflation in Turkey.
The Reserve Bank of Australia debated a rate hike before unanimously holding the cash rate steady.
Tourism Holdings (ASX:THL) generated a statutory net profit after tax of $39.9 million for the year ended June 30.
Abacus Group (ASX:ABG) delivered funds from operations of $81.2 million for the full year ended June 30.
As Australia's earnings season peaks, the likes of BHP and Woodside Energy are among the winners emerging, as elevated commodity prices offset headwinds. And Bloomberg Intelligence says Australian banks are positioned for significant margin expansion and a structural return on equity uplift in fiscal 2027. Alphinity Investment Management Client Portfolio Manager and Investment Specialist Elfreda Jonker joins "Bloomberg: The Asia Trade" to discuss why Australian stocks are priced for perfection, but delivering for average.
MyState (ASX:MYS) delivered a 41.2% increase in underlying net profit after tax to $58.3 million for the 2026 financial year.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy